Diane Sullivan is a seasoned healthcare executive and strategic advisor with extensive experience in the global healthcare landscape. Currently serving as a board director for Amarin Corporation and Lexicon Pharmaceuticals, they have previously held key leadership roles at AstraZeneca, Pfizer, and GlaxoSmithKline, notably as Chief Commercial Officer at The Medicines Company during its record-breaking acquisition by Novartis in 2020. Diane is the founder of Diane E Sullivan LLC, specializing in commercial strategy development, market access, and business development in the life sciences sector. Their contributions extend to various boards and councils, showcasing a commitment to advancing healthcare innovation.